Shire raises outlook after Q1 earnings beat
May 01, 2014 at 07:11 AM EDT
LONDON, May 1 (Reuters) - Shire, a pharmaceutical group created by acquisition, soundly beat expectations with a 38 percent rise in first-quarter earnings, underlining its own appeal as a target in the latest wave of deal making in the sector.
